Open Access
Multimodality therapy in subclassified stage IIIA–N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management
Author(s) -
HansStefan Hofmann,
Jan Braess,
Susanne Leipelt,
Michael Allgäuer,
Monika KlinkhammerSchalke,
Tamas Szoeke,
Christian Großer,
Michael Pfeifer,
Michael Ried
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.05.203
Subject(s) - medicine , stage (stratigraphy) , lung cancer , multimodality , oncology , linguistics , philosophy , paleontology , biology
Non-small cell lung cancer (NSCLC) with mediastinal lymph node involvement (N2) is a heterogeneous entity. The objective of this analysis is to investigate the results of treatment strategies for N2-positive patients.